Department of Orthopaedic Surgery, Geriatric Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Department of Orthopaedic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Drug Des Devel Ther. 2020 Jul 7;14:2645-2655. doi: 10.2147/DDDT.S255823. eCollection 2020.
Osteoarthritis (OA) is one of the most prevalent and degenerative diseases with complicated pathology including articular cartilage degradation, subchondral sclerosis and synovitis. Chondrocytes play a crucial role in maintaining cartilage integrity.
Primary chondrocytes were treated with 10 ng/mL IL-1β alone, or pre-treated with 20 μM baicalin for 5 h followed by co-treatment with 20 μM baicalin and 10 ng/mL IL-1β. CCK-8 assay was used to assess cell viability, and cell apoptosis was analyzed by both PI/FITC-Annexin V staining and quantitating apoptosis-related Bcl-2, Bax and cleaved-caspase-3 expression at both protein and mRNA level by Western blotting and qRT-PCR, respectively. Chondrocytes were transfected with miRNA-766-3p mimic and autophagy flux was examined by LC3, Beclin and p62 Western blotting and by Cyto-ID assay to quantify autophagic vacuoles.
Baicalin treatment decreased the apoptosis rate and the expressions of pro-apoptotic proteins induced by IL-1β, up-regulated anti-apoptotic Bcl-2 expression, and inhibited the degradation of ECM. Baicalin increased autophagy through up-regulating the autophagy markers Beclin-1 expression and LC3 Ⅱ/LC3 Ⅰ ratio and promoting autophagic flux. Contrarily, autophagy inhibition partially alleviated the beneficial effects of baicalin on ECM synthesis and anti-apoptosis in the chondrocytes treated with L-1β. Furthermore, the differential expressional profiles of miR-766-3p and apoptosis-inducing factor mitochondria-associated 1 (AIFM1) were determined in IL-1β and IL-1β + baicalin-treated chondrocytes, and we confirmed AIFM1 was a target of miR-766-3p. MiR-766-3p overexpression suppressed apoptosis and facilitated autophagy and ECM synthesis in the chondrocytes through decreasing AIFM1. Contrarily, silencing of miR-766-3p inhibited chondrocyte autophagy and promoted apoptosis, and this effect could be reversed by AIFM1 silence.
Baicalin protects human OA chondrocytes against IL-1β-induced apoptosis and the degradation of ECM through activating autophagy via miR-766-3p/AIFM1 axis and serves as a potential therapeutic candidate for OA treatment.
骨关节炎(OA)是一种最常见和退行性疾病,其病理学包括关节软骨降解、软骨下硬化和滑膜炎等十分复杂。软骨细胞在维持软骨完整性方面起着至关重要的作用。
用 10ng/mLIL-1β 单独处理原代软骨细胞,或用 20μM 黄芩苷预处理 5 小时,然后用 20μM 黄芩苷和 10ng/mLIL-1β 共同处理。CCK-8 测定法评估细胞活力,通过 PI/FITC-Annexin V 染色和 Western blot 定量分析凋亡相关蛋白 Bcl-2、Bax 和 cleaved-caspase-3 的表达水平,通过 qRT-PCR 定量分析 mRNA 水平的表达水平。用 miRNA-766-3p 模拟物转染软骨细胞,并通过 LC3、Beclin 和 p62 Western blot 和 Cyto-ID 测定法检测自噬流,以定量自噬小体。
黄芩苷处理降低了 IL-1β 诱导的细胞凋亡率和促凋亡蛋白的表达,上调了抗凋亡 Bcl-2 的表达,并抑制了细胞外基质的降解。黄芩苷通过上调自噬标志物 Beclin-1 的表达和 LC3 Ⅱ/LC3 Ⅰ 比值以及促进自噬流来增加自噬。相反,自噬抑制部分减轻了黄芩苷对 IL-1β 处理的软骨细胞中 ECM 合成和抗凋亡的有益作用。此外,在 IL-1β 和 IL-1β+黄芩苷处理的软骨细胞中确定了 miR-766-3p 和凋亡诱导因子线粒体相关 1(AIFM1)的差异表达谱,并证实 AIFM1 是 miR-766-3p 的靶标。miR-766-3p 过表达通过降低 AIFM1 抑制了软骨细胞凋亡并促进了自噬和 ECM 合成。相反,沉默 miR-766-3p 抑制了软骨细胞自噬并促进了凋亡,并且通过沉默 AIFM1 可以逆转这种作用。
黄芩苷通过 miR-766-3p/AIFM1 轴激活自噬来保护人 OA 软骨细胞免受 IL-1β 诱导的凋亡和 ECM 降解,是 OA 治疗的潜在治疗候选药物。